100 related articles for article (PubMed ID: 7778947)
1. [Clinical immunology of hepato-splenic bilharziasis].
Esterre P; Boisier P; Ravaolimalala VA; Roux J
Arch Inst Pasteur Madagascar; 1994; 61(1):28-30. PubMed ID: 7778947
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
3. Immunity and morbidity in human schistosomiasis mansoni.
Butterworth AE; Curry AJ; Dunne DW; Fulford AJ; Kimani G; Kariuki HC; Klumpp R; Koech D; Mbugua G; Ouma JH
Trop Geogr Med; 1994; 46(4 Spec No):197-208. PubMed ID: 7825222
[TBL] [Abstract][Full Text] [Related]
4. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
Hagan P; Blumenthal UJ; Dunn D; Simpson AJ; Wilkins HA
Nature; 1991 Jan; 349(6306):243-5. PubMed ID: 1898985
[TBL] [Abstract][Full Text] [Related]
5. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.
Demeure CE; Rihet P; Abel L; Ouattara M; Bourgois A; Dessein AJ
J Infect Dis; 1993 Oct; 168(4):1000-8. PubMed ID: 7690821
[TBL] [Abstract][Full Text] [Related]
6. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.
Dunne DW; Pearce EJ
Microbes Infect; 1999 Jun; 1(7):553-60. PubMed ID: 10603572
[No Abstract] [Full Text] [Related]
7. Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments.
Petroianu A; Antunes LJ
J Int Med Res; 1998; 26(1):43-9. PubMed ID: 9513076
[TBL] [Abstract][Full Text] [Related]
8. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulins in patients with schistosomiasis mansoni.
Guimarães RX; Prícoli TI; Novo NF; de Paiva ER
Arq Gastroenterol; 1979; 16(1):3-7. PubMed ID: 475612
[TBL] [Abstract][Full Text] [Related]
10. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
Degu G; Mengistu G; Jones J
Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
[TBL] [Abstract][Full Text] [Related]
11. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A
J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485
[TBL] [Abstract][Full Text] [Related]
12. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations.
Remoué F; Rogerie F; Gallissot MC; Guyatt HL; Neyrinck JL; Diakkhate MM; Niang M; Butterworth AE; Auriault C; Capron A; Riveau G
J Infect Dis; 2000 May; 181(5):1855-9. PubMed ID: 10823801
[TBL] [Abstract][Full Text] [Related]
13. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
[TBL] [Abstract][Full Text] [Related]
14. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
Khalil HM; Makled MK; el Sebai MM; el Naggar MK
J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
[No Abstract] [Full Text] [Related]
15. Immuno-epidemiology of Ascaris lumbricoides infection in a high transmission community: antibody responses and their impact on current and future infection intensity.
King EM; Kim HT; Dang NT; Michael E; Drake L; Needham C; Haque R; Bundy DA; Webster JP
Parasite Immunol; 2005 Mar; 27(3):89-96. PubMed ID: 15882235
[TBL] [Abstract][Full Text] [Related]
16. T cell-dependent immunodepression in vivo in Schistosoma mansoni infected patients.
Muniz-Junqueira MI; Tosta CE; Prata A
Rev Soc Bras Med Trop; 1990; 23(1):27-31. PubMed ID: 2128545
[TBL] [Abstract][Full Text] [Related]
17. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
Salem SA; Makled MK; Abel-Wahab MF; Sedky A; Montasser MF; Bishara SA; Ragheb MM; Younis TA
J Egypt Soc Parasitol; 1987 Dec; 17(2):785-96. PubMed ID: 3121771
[No Abstract] [Full Text] [Related]
18. Discriminating acute from chronic human schistosomiasis mansoni.
Beck L; Van-Lüme DS; Souza JR; Domingues AL; Favre T; Abath FG; Montenegro SM
Acta Trop; 2008; 108(2-3):229-33. PubMed ID: 18851939
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor in hepatosplenic schistosomiasis.
Zwingenberger K; Irschick E; Vergetti Siqueira JG; Correia Dacal AR; Feldmeier H
Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
[TBL] [Abstract][Full Text] [Related]
20. Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni.
Fallon PG; Gibbons J; Vervenne RA; Richardson EJ; Fulford AJ; Kiarie S; Sturrock RF; Coulson PS; Deelder AM; Langermans JA; Thomas AW; Dunne DW
J Infect Dis; 2003 Mar; 187(6):939-45. PubMed ID: 12660940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
